Sale!

DMD Gene Muscular Dystrophy Duchenne Type Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DMD Gene Muscular Dystrophy Duchenne Type Genetic Test” is a specialized diagnostic procedure aimed at detecting mutations in the DMD gene, which is responsible for Duchenne Muscular Dystrophy (DMD). This condition is a severe form of muscular dystrophy that primarily affects boys, leading to muscle weakness and degeneration over time. Early diagnosis through genetic testing can provide valuable information for managing the condition, enabling timely interventions and support.

The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. By analyzing a sample of the patient’s DNA, the test identifies specific mutations in the DMD gene that are indicative of Duchenne Muscular Dystrophy. This process involves sophisticated technology and expertise to ensure accurate results.

The cost of the DMD Gene Muscular Dystrophy Duchenne Type Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the intricate nature of genetic testing and the specialized analysis required to pinpoint mutations associated with the condition. While the cost may seem significant, the value of the information gained from this test is immeasurable for affected families, providing them with a clear diagnosis and guiding treatment and management decisions for Duchenne Muscular Dystrophy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DMD Gene Muscular Dystrophy Duchenne Type Genetic Test

Welcome to DNA Labs UAE, where we offer the DMD Gene Muscular Dystrophy Duchenne Type Genetic Test. This test helps diagnose and identify mutations in the DMD gene, which is responsible for producing the essential dystrophin protein for muscle fiber structure and function.

Test Components and Price

  • Components: DMD Gene Muscular Dystrophy Duchenne Type Genetic Test
  • Price: 4400.0 AED

Sample Condition and Report Delivery

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks

Method and Test Type

  • Method: NGS Technology (Next-Generation Sequencing)
  • Test Type: Neurological Disorders

Doctor and Test Department

  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the DMD Gene Muscular Dystrophy Duchenne Type Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by DMD Gene Muscular Dystrophy, Duchenne type.

Test Details

The DMD gene is responsible for producing dystrophin, a protein essential for muscle fiber structure and function. Mutations in the DMD gene can lead to Duchenne muscular dystrophy (DMD). Our NGS genetic testing method analyzes the DNA sequence of the DMD gene to identify specific mutations or variations associated with DMD.

For the test, a DNA sample is obtained, usually through a blood sample or a cheek swab. The DNA is then sequenced using advanced NGS technology, allowing for the analysis of multiple genes simultaneously. The resulting DNA sequence data is compared to a reference sequence to identify any variations or mutations in the DMD gene.

This genetic testing is useful for confirming a diagnosis of DMD in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in females who may have an increased risk of passing on the DMD gene mutation to their children.

NGS genetic testing for DMD has significantly improved the accuracy and efficiency of genetic diagnosis. It can detect various DMD gene mutations, including small insertions or deletions, single nucleotide changes, and large gene rearrangements. This information is crucial for providing accurate genetic counseling, guiding treatment decisions, and potentially identifying individuals who may benefit from specific therapies or clinical trials.

Test Name DMD Gene Muscular dystrophy Duchenne type Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DMD Gene Muscular dystrophy, Duchenne type NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DMD Gene Muscular dystrophy, Duchenne type
Test Details

The DMD gene is responsible for producing a protein called dystrophin, which is essential for maintaining the structure and function of muscle fibers. Mutations in the DMD gene can lead to a type of muscular dystrophy known as Duchenne muscular dystrophy (DMD).

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the DMD gene. It allows for the identification of specific mutations or variations within the gene that may be associated with DMD.

NGS genetic testing for DMD involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using advanced technology that can analyze multiple genes simultaneously. The resulting DNA sequence data is compared to a reference sequence to identify any variations or mutations in the DMD gene.

This type of genetic testing can help confirm a diagnosis of DMD in individuals with symptoms suggestive of the condition. It can also be used for carrier testing in females who may have an increased risk of passing on the DMD gene mutation to their children.

NGS genetic testing for DMD has significantly improved the accuracy and efficiency of genetic diagnosis. It allows for the detection of a wide range of DMD gene mutations, including small insertions or deletions, single nucleotide changes, and large gene rearrangements. This information is crucial for providing accurate genetic counseling, guiding treatment decisions, and potentially identifying individuals who may benefit from specific therapies or clinical trials.